Archive | About Tron

PHD PROGRAM

5 excellent reasons to do your PhD at TRON 1. Cutting edge biomedical research We offer exceptional opportunities for ambitious scientists to investigate innovative diagnostics and therapies for the treatment of cancer and other severe diseases with high medical need. TRON currently has more than 15 doctoral students doing cutting edge translational research in RNA

Supervisory Board

Dr. Carola Zimmermann (chairperson) Ministry of Science, Education and Culture of the state Rhineland-Palatinate Dr. Waltraud Kreutz-Gers (deputy chairperson) Chancellor of the Johannes Gutenberg-University Mainz Christian Merk Ministry of Fincance of the state Rhineland-Palatinate Prof. Dr. Dr. h.c. mult. Ernst Theodor Rietschel Professor Emeritus, former director of the Leibniz Association, former Chairman of the Berlin Institute of Health

Management

MANAGEMENT   Michael H. Föhlings … is Managing Director (CFO) of TRON.   During his 30 years career in auditing, glass, steel and polymer industries, Michael has held diverse senior financial and general management functions in British, Anglo-Dutch and Swiss multinational companies. Concomitantly he was also a member of company boards in Germany, Italy, Spain,

Our Story

Challenges in Translational Medicine Translating scientific concepts into clinical applications is a major contemporary challenge in medical health care. Expiring patents, empty pipelines and the increasing complexity of product development in the era of individualized medicine mean that even large pharmaceutical companies cannot address these challenges alone. At the same time, increasing regulatory requirements and

Careers at TRON

TRON is a rapidly growing biopharmaceutical institute that develops new diagnostics and drugs for the treatment of cancer and other diseases of the immune system. TRON is located in Mainz, Germany, and is part of a strong regional network of science and industry focusing on immunotherapy. TRON collaborates with internationally renowned research groups and leading biotech